Literature DB >> 28251514

Human-Induced Pluripotent Stem Cell-Based Modeling of Cardiac Storage Disorders.

Bradley C Nelson1, Sherin I Hashem1, Eric D Adler2.   

Abstract

PURPOSE OF REVIEW: The aim of this study is to review the published human-induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) models of cardiac storage disorders and to evaluate the limitations and future applications of this technology. RECENT
FINDINGS: Several cardiac storage disorders (CSDs) have been modeled using patient-specific hiPSC-CMs, including Anderson-Fabry disease, Danon disease, and Pompe disease. These models have shown that patient-specific hiPSC-CMs faithfully recapitulate key phenotypic features of CSDs and respond predictably to pharmacologic manipulation. hiPSC-CMs generated from patients with CSDs are representative models of the patient disease state and can be used as an in vitro system for the study of human cardiomyocytes. While these models suffer from several limitations, they are likely to play an important role in future mechanistic studies of cardiac storage disorders and the development of targeted therapeutics for these diseases.

Entities:  

Keywords:  Cardiac storage disorders; Cardiomyocyte; Disease modeling; Induced pluripotent stem cells

Mesh:

Year:  2017        PMID: 28251514     DOI: 10.1007/s11886-017-0829-y

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  109 in total

1.  Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome).

Authors:  Jakub Tolar; In-Hyun Park; Lily Xia; Chris J Lees; Brandon Peacock; Beau Webber; Ron T McElmurry; Cindy R Eide; Paul J Orchard; Michael Kyba; Mark J Osborn; Troy C Lund; John E Wagner; George Q Daley; Bruce R Blazar
Journal:  Blood       Date:  2010-10-29       Impact factor: 22.113

2.  Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state.

Authors:  Jennifer C Moore; Jidong Fu; Yau-Chi Chan; Dawei Lin; Ha Tran; Hung-Fat Tse; Ronald A Li
Journal:  Biochem Biophys Res Commun       Date:  2008-05-27       Impact factor: 3.575

Review 3.  High throughput physiological screening of iPSC-derived cardiomyocytes for drug development.

Authors:  Juan C Del Álamo; Derek Lemons; Ricardo Serrano; Alex Savchenko; Fabio Cerignoli; Rolf Bodmer; Mark Mercola
Journal:  Biochim Biophys Acta       Date:  2016-03-04

4.  Patient-Specific Induced Pluripotent Stem Cell-Derived RPE Cells: Understanding the Pathogenesis of Retinopathy in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency.

Authors:  Padmini P Polinati; Tanja Ilmarinen; Ras Trokovic; Tuulia Hyotylainen; Timo Otonkoski; Anu Suomalainen; Heli Skottman; Tiina Tyni
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

5.  Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions.

Authors:  Xiaojun Lian; Jianhua Zhang; Samira M Azarin; Kexian Zhu; Laurie B Hazeltine; Xiaoping Bao; Cheston Hsiao; Timothy J Kamp; Sean P Palecek
Journal:  Nat Protoc       Date:  2012-12-20       Impact factor: 13.491

6.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population.

Authors:  Lei Yang; Mark H Soonpaa; Eric D Adler; Torsten K Roepke; Steven J Kattman; Marion Kennedy; Els Henckaerts; Kristina Bonham; Geoffrey W Abbott; R Michael Linden; Loren J Field; Gordon M Keller
Journal:  Nature       Date:  2008-04-23       Impact factor: 49.962

7.  Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease.

Authors:  Cristina Chimenti; Nazha Hamdani; Nicky M Boontje; Francesco DeCobelli; Antonio Esposito; Jean G F Bronzwaer; Ger J M Stienen; Matteo A Russo; Walter J Paulus; Andrea Frustaci; Jolanda van der Velden
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

8.  Long-term enzyme replacement therapy for pompe disease with recombinant human alpha-glucosidase derived from chinese hamster ovary cells.

Authors:  Massimiliano Rossi; Giancarlo Parenti; Roberto Della Casa; Alfonso Romano; Giuseppina Mansi; Teresa Agovino; Felice Rosapepe; Carlo Vosa; Ennio Del Giudice; Generoso Andria
Journal:  J Child Neurol       Date:  2007-05       Impact factor: 1.987

9.  Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes.

Authors:  Donghui Zhang; Ilya Y Shadrin; Jason Lam; Hai-Qian Xian; H Ralph Snodgrass; Nenad Bursac
Journal:  Biomaterials       Date:  2013-05-02       Impact factor: 12.479

Review 10.  Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.

Authors:  Elizabeth A Braunlin; Paul R Harmatz; Maurizio Scarpa; Beatriz Furlanetto; Christoph Kampmann; James P Loehr; Katherine P Ponder; William C Roberts; Howard M Rosenfeld; Roberto Giugliani
Journal:  J Inherit Metab Dis       Date:  2011-07-09       Impact factor: 4.982

View more
  2 in total

Review 1.  Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy.

Authors:  Barry J Byrne; David D Fuller; Barbara K Smith; Nathalie Clement; Kirsten Coleman; Brian Cleaver; Lauren Vaught; Darin J Falk; Angela McCall; Manuela Corti
Journal:  Ann Transl Med       Date:  2019-07

Review 2.  Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells.

Authors:  Tarek Khedro; Jason M Duran; Eric D Adler
Journal:  Curr Cardiol Rep       Date:  2022-06-03       Impact factor: 3.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.